[go: up one dir, main page]

FR2733753B1 - Derives iodes de monosaccharides utilisables comme produits radiopharmaceutiques - Google Patents

Derives iodes de monosaccharides utilisables comme produits radiopharmaceutiques

Info

Publication number
FR2733753B1
FR2733753B1 FR9505214A FR9505214A FR2733753B1 FR 2733753 B1 FR2733753 B1 FR 2733753B1 FR 9505214 A FR9505214 A FR 9505214A FR 9505214 A FR9505214 A FR 9505214A FR 2733753 B1 FR2733753 B1 FR 2733753B1
Authority
FR
France
Prior art keywords
iodic
radiopharmaceuticals
monosaccharides
derivatives
iodic derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9505214A
Other languages
English (en)
Other versions
FR2733753A1 (fr
Inventor
Gilles Bignan
Catherine Guezzi
Christel Henry
Francoise Koumanov
Christophe Morin
Lionel Ogier
Laurent Mauclaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CIS Bio International SA
Original Assignee
CIS Bio International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CIS Bio International SA filed Critical CIS Bio International SA
Priority to FR9505214A priority Critical patent/FR2733753B1/fr
Priority to EP96914263A priority patent/EP0824537A1/fr
Priority to PCT/FR1996/000655 priority patent/WO1996034872A1/fr
Publication of FR2733753A1 publication Critical patent/FR2733753A1/fr
Application granted granted Critical
Publication of FR2733753B1 publication Critical patent/FR2733753B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9505214A 1995-05-02 1995-05-02 Derives iodes de monosaccharides utilisables comme produits radiopharmaceutiques Expired - Lifetime FR2733753B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9505214A FR2733753B1 (fr) 1995-05-02 1995-05-02 Derives iodes de monosaccharides utilisables comme produits radiopharmaceutiques
EP96914263A EP0824537A1 (fr) 1995-05-02 1996-04-30 Derives iodes de monosaccharides utilisables comme produits radiopharmaceutiques
PCT/FR1996/000655 WO1996034872A1 (fr) 1995-05-02 1996-04-30 Derives iodes de monosaccharides utilisables comme produits radiopharmaceutiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505214A FR2733753B1 (fr) 1995-05-02 1995-05-02 Derives iodes de monosaccharides utilisables comme produits radiopharmaceutiques

Publications (2)

Publication Number Publication Date
FR2733753A1 FR2733753A1 (fr) 1996-11-08
FR2733753B1 true FR2733753B1 (fr) 2002-06-21

Family

ID=9478606

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9505214A Expired - Lifetime FR2733753B1 (fr) 1995-05-02 1995-05-02 Derives iodes de monosaccharides utilisables comme produits radiopharmaceutiques

Country Status (3)

Country Link
EP (1) EP0824537A1 (fr)
FR (1) FR2733753B1 (fr)
WO (1) WO1996034872A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9705521D0 (en) 1997-03-18 1997-05-07 Univ Sheffield The use of mononuclear phagocytes in the vivo imaging of hypoxic/ischaemic tissue
WO1999020316A1 (fr) * 1997-10-20 1999-04-29 Board Of Regents, The University Of Texas System Radiotraceurs d'emission monophotonique et leurs methodes d'utilisation
ATE479695T1 (de) * 2004-06-24 2010-09-15 Toyo Suisan Kaisha Sulfopyranosylacylglycerol-derivate zur anwendung in kombination mit bestrahlung in einer tumor- radiotherapie
FR2934048A1 (fr) * 2008-07-18 2010-01-22 Univ Joseph Fourier Nouveau procede de mesure de la resistance a l'insuline

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601000B1 (fr) * 1986-07-03 1988-10-21 Centre Nat Rech Scient Procede de radio-iodation de gangliosides par voie enzymatique

Also Published As

Publication number Publication date
EP0824537A1 (fr) 1998-02-25
FR2733753A1 (fr) 1996-11-08
WO1996034872A1 (fr) 1996-11-07

Similar Documents

Publication Publication Date Title
EE9600134A (et) Nukleosiidide analoogide diastereoselektiivne valmistamismeetod
EE04277B1 (et) Taksoidide klassi kuuluvate derivaatide valmistamismeetod
BR9605309A (pt) Composições de derivados piperazina
MA23850A1 (fr) Procede de preparation de compositions vaccinantes
MA23918A1 (fr) Procede de preparation de compositions vaccinantes
LU90115B1 (fr) Formulation orale de 2-méthyl-thiéno-benzodiazépine
BR9503740A (pt) Composiçao estabilizada contra os efeitos nocivos de radiaçao actínica
IT1276979B1 (it) Composizioni fluoroelastomeriche
MA23814A1 (fr) Procede de preparation de compositions vaccinantes
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
PT1014987E (pt) Composicoes orais de levosimendano
IL116270A0 (en) Stabilized compositions of polyvinyl chloride
HUP0004071A3 (en) Pharmaceutical compositions comprising prostaglandin derivatives
NZ321821A (en) Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands
GB9507882D0 (en) Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
DK1041869T3 (da) På anvendelsesstedet udformet EMI pakning
DK0747346T3 (da) N-acyl-2-arylcyclopropylmethylaminderivater som melatonerge midler
IT1272922B (it) Procedimento per la preparazione di composti metallocenici
FR2733753B1 (fr) Derives iodes de monosaccharides utilisables comme produits radiopharmaceutiques
IT1269916B (it) Procedimento migliorato per la sintesi di dimetilcarbonato
PL320889A1 (en) Derivatives of thiene oxazinone useful as antiviral agent
EP0804205A4 (fr) Derives de 4-aza-19-norandrostane
NO991679L (no) Fremgangsmaate for fremstilling av fenoksyfenylsulfonylhalider
DK0851856T3 (da) Indolderivater som melatoninerge analoger
FI974058A0 (fi) Foerlaengningsstycke med tillaeggsdelar foer uppsamling av olja eller liknande

Legal Events

Date Code Title Description
TP Transmission of property